Technology Impact Award (cancer immunotherapy)
The Technology Impact Award from the Cancer Research Institute provides seed funding to address the gap between technology development and clinical application of cancer immunotherapies. The
Cancer research funding and funders.
The Technology Impact Award from the Cancer Research Institute provides seed funding to address the gap between technology development and clinical application of cancer immunotherapies. The
The ASTRO-ACS Clinician Scientist Development Grant are funded by the American Cancer Society and the American Society for Radiation Oncology (ASTRO) to support radiation oncologists
American Cancer Society´s Research Scholar Grants provide funding for early-career independent researchers (within the first 10 years of independent research career) to support research on
The Postdoctoral Fellowships from the American Cancer Society provides funding for doctoral graduates within 3 years of graduation to continue their training in cancer research,
The Grant for Basic and Translational Research in Children’s Brain Tumors from A Kids’ Brain Tumor Cure seeks to fund research for basic and translational
The Open Funding Call from the Bone Cancer Research Trust supports postdoctoral researchers worldwide working on primary bone cancer. As the Trust has other grant
The EACR Travel Fellowships provided by the European Association for Cancer Research (EACR) and World Cancer Research support students and early career cancer researchers who
The 2022 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from Mallinckrodt Pharmaceuticals, supports
The Prevention and Population Research Project Award from Cancer Research UK (CRUK) supports research in the UK looking into cancer aetiology and prevention. Research areas
The EACR-Boehringer Ingelheim Postdoctoral Fellowships are provided by the European Association for Cancer Research (EACR) and Boehringer Ingelheim, to support postdoctoral researchers in cancer research.